Impact of methotrexate on first-dose COVID-19 mRNA vaccination

por Connolly, Caoilfhionn M, Paik, Julie J
Publicado 2021

Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal

por Connolly, Caoilfhionn M, Paik, Julie J
Publicado 2022

SARS-CoV-2 vaccination in the immunocompromised host

por Connolly, Caoilfhionn M., Paik, Julie J.
Publicado 2022

Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease

por Frey, Sarah, Chowdhury, Reezwana, Connolly, Caoilfhionn M., Werbel, William A., Segev, Dorry L., Parian, Alyssa M.
Publicado 2022

Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis

por Hughes, Robert M., Frey, Sarah, Teles, Mayan, Connolly, Caoilfhionn M., Segev, Dorry L., Werbel, William A., Chen, Po-Hung
Publicado 2023

Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients

por Mitchell, Jonathan, Connolly, Caoilfhionn M., Chiang, Teresa Po-Yu, Alejo, Jennifer L., Werbel, William A., Segev, Dorry L., Massie, Allan B.
Publicado 2022

Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis

por Wallwork, Rachel, Connolly, Caoilfhionn M, Shneyderman, Matthew, McMahan, Zsuzsanna, Mecoli, Christopher A, Wigley, Fredrick, Hummers, Laura K, Shah, Ami A, Paik, Julie J
Publicado 2022

Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccination

por Frey, Sarah, Connolly, Caoilfhionn M, Chiang, Teresa Po-Yu, Teles, Mayan, Alejo, Jennifer L, Boyarsky, Brian J, Christopher-Stine, Lisa, Werbel, William A, Segev, Dorry L, Paik, Julie J
Publicado 2021

Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series

por Teles, Mayan S, Connolly, Caoilfhionn M, Wallwork, Rachel, Frey, Sarah, Chiang, Teresa Po-Yu, Alejo, Jennifer L, Albayda, Jemima, Christopher-Stine, Lisa, Segev, Dorry L, Werbel, William A, Paik, Julie J
Publicado 2022

Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease

por Connolly, Caoilfhionn M, Frey, Sarah, Chiang, Teresa Po-Yu, Teles, Mayan, Alejo, Jennifer L, Albayda, Jemima, Shah, Ami A, Werbel, William A, Segev, Dorry L, Christopher-Stine, Lisa, Paik, Julie J
Publicado 2022

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease

por Frey, Sarah, Chiang, Teresa Po-Yu, Connolly, Caoilfhionn M, Teles, Mayan, Alejo, Jennifer L, Boyarsky, Brian J, Christopher-Stine, Lisa, Werbel, William A, Massie, Allan B, Segev, Dorry L, Paik, Julie J
Publicado 2022

Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases

por Connolly, Caoilfhionn M, Chiang, Teresa Po-Yu, Teles, Mayan, Frey, Sarah, Alejo, Jennifer L, Massie, Allan, Shah, Ami A, Albayda, Jemima, Christopher-Stine, Lisa, Werbel, William A, Segev, Dorry L, Paik, Julie J
Publicado 2022

Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies

por Lee, Jenny M., Figueroa, Alexis, Sachithanandham, Jaiprasath, Li, Maggie, Connolly, Caoilfhionn M., Shapiro, Janna R., Chen, Yiqun, Jones, Michelle, Dhara, Venkata Gayatri, Towns, Marilyn, Lee, John S., Peralta, Stephanie R., Milstone, Aaron M., Betenbaugh, Michael, Debes, Amanda K., Blankson, Joel, Sitaras, Ioannis, Yoon, Steve, Thompson, Elizabeth A., Bingham, Clifton O., Klein, Sabra L., Pekosz, Andrew, Bailey, Justin R.
Publicado 2023